Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.

about

Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.

Item

http://www.wikidata.org/entity/Q54267479

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Primary Gastric EBV-positive D ...... Plasmablastic Differentiation.

@en

Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma

@nl

type

Item

label

Primary Gastric EBV-positive D ...... Plasmablastic Differentiation.

@en

Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma

@nl

prefLabel

Primary Gastric EBV-positive D ...... Plasmablastic Differentiation.

@en

Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma

@nl

P1476

Primary Gastric EBV-positive D ...... Plasmablastic Differentiation.

@en

P2093

Dengfeng Cao

http://www.w3.org/2001/XMLSchema#string

Jinping Lai

http://www.w3.org/2001/XMLSchema#string

Jose Trevino

http://www.w3.org/2001/XMLSchema#string

Lijun Yang

http://www.w3.org/2001/XMLSchema#string

Ming Hu

http://www.w3.org/2001/XMLSchema#string

Xiuli Liu

http://www.w3.org/2001/XMLSchema#string

P2860

PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma

Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.

CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options.

Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age.

The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Expression pattern of XBP1(S) in human B-cell lymphomas

EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.

CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.

P304

413-417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21873/INVIVO.11255

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29475930

http://www.w3.org/2001/XMLSchema#string

P932

5905215

http://www.w3.org/2001/XMLSchema#string